TOI 5. Use of a Next-Generation Decellularized Dermal Allograft as a Cost-Effective Treatment of Acute and Chronic Wounds

The number of individuals with chronic wounds in the United States continues to grow, with millions of people affected yearly, placing a huge financial burden on our health care system. In addition, acute wounds in patients with multiple comorbidities threaten patients ’ quality of life and ability to perform activities of daily living. The use of a next-generation decellularized dermal allograft (DDA) can significantly decrease healing times, therefore improving patients’ quality of life as well as reducing the overall economic cost.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Source Type: research